These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28794142)

  • 1. Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities.
    Corrao S; Brunori G; Lupo U; Perticone F
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28794142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials.
    Li C; Cheng W; Guo J; Guan W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():799-808. PubMed ID: 31114181
    [No Abstract]   [Full Text] [Related]  

  • 3. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
    Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
    BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.
    Manoharan A; Short PM; Anderson WJ; Lipworth BJ
    Lung; 2014 Oct; 192(5):649-52. PubMed ID: 24952426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
    Kardos P; Worsley S; Singh D; Román-Rodríguez M; Newby DE; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2885-2895. PubMed ID: 27932872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Wu J; Ye Y; Li C; Zhou W; Chang R
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):255-265. PubMed ID: 31306366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?
    Adesanoye DT; Willey CJ
    Ann Pharmacother; 2017 Oct; 51(10):855-861. PubMed ID: 28573879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled short-acting bronchodilators for COPD.
    Med Lett Drugs Ther; 2017 Apr; 59(1518):e62-e63. PubMed ID: 28377551
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled long-acting bronchodilators for COPD.
    Med Lett Drugs Ther; 2017 Apr; 59(1518):e64-e65. PubMed ID: 28377552
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
    Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
    Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.
    Wang MT; Lai JH; Tsai CL; Liou JT
    J Food Drug Anal; 2019 Jul; 27(3):657-670. PubMed ID: 31324282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease.
    Ramadan WH; Kabbara WK; El Khoury GM; Al Assir SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2347-56. PubMed ID: 26586940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to study the effect of bronchodilators on smoke retention in COPD patients: study protocol for a randomized controlled trial.
    van Dijk WD; Scheepers PT; Cremers R; Lenders JW; Klerx W; van Weel C; Schermer TR; Heijdra Y
    Trials; 2011 Feb; 12():37. PubMed ID: 21310040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review.
    Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():331-8. PubMed ID: 24729699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and COPD: dangerous liaisons?
    Rabe KF; Hurst JR; Suissa S
    Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30282634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.